Financing

Jaguar Animal Health headed towards $70m IPO financing

Posted on 29 August 2014

Tags: ,

Financing news: The veteran of two biotech companies — Napo Pharmaceuticals Inc. and Shaman Pharmaceuticals Inc. — is leading a new company toward a planned $70 million initial public offering .

San Francisco’s Jaguar Animal Health Inc., which would trade on the NASDAQ exchange as “JAGX,” is focused on gastrointestinal drugs for animals.

Jaguar had cash and equivalents of $4.3 million as of June 30. It lost $4.2 million in the first six months of this year.

For further deal information visit Current Agreements (subscription required)

Related

Read: more on financing deals in pharma, biotech, life science partnering deal news, insights and glossary

Report: Finding Biopharma and Collaboration Partners

Related reports:  Entire Current Partnering reports catalog

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering Insight Financing Scorecard – view top life science financing deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Print Friendly, PDF & Email

Leave a Reply